Shenzhen Historical Income Statement

002551 Stock

3.38 0.08 2.42%

Historical analysis of Shenzhen Glory income statement accounts such as Selling General Administrative of 103.2 M, Total Revenue of 1.2 B or Cost Of Revenue of 901.2 M can show how well Shenzhen Glory Medical performed in making a profits. Evaluating Shenzhen Glory income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shenzhen Glory's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Shenzhen Glory Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shenzhen Glory Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Shenzhen Income Statement Analysis

Shenzhen Glory Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Glory shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Shenzhen Glory Income Statement Chart

At present, Shenzhen Glory's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 103.2 M, whereas Operating Income is projected to grow to (18.9 M).

Selling General Administrative Total Revenue Cost Of Revenue Research Development Net Income From Continuing Ops Ebit

Total Revenue

Total revenue comprises all receipts Shenzhen Glory Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Cost Of Revenue

Cost of Revenue is found on Shenzhen Glory Medical income statement and represents the costs associated with goods and services Shenzhen Glory provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Shenzhen Glory's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shenzhen Glory Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Gross Profit	362.9M	221.9M	197.6M	319.4M
Research Development	52.4M	48.2M	40.1M	52.2M

Gross Profit Research Development

Shenzhen Glory income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.66	0.72	0.57	0.62	0.49	0.32	0.48	0.56	0.61	0.06	0.49	0.58	0.52	-0.08	-0.02	-0.08	0.19	0.43	-0.18
Total Revenue	0.66		0.73	0.99	0.4	0.29	0.12	0.71	0.87	0.25	-0.53	0.17	0.26	0.47	-0.07	-0.2	0.38	0.05	0.06	0.02
Operating Income	0.72	0.73		0.65	0.84	0.75	0.59	0.86	0.53	0.79	0.02	0.74	0.8	0.81	0.13	0.03	-0.14	0.04	0.68	-0.35
Cost Of Revenue	0.57	0.99	0.65		0.3	0.2	0.06	0.67	0.87	0.13	-0.6	0.07	0.15	0.4	-0.08	-0.24	0.44	0.02	-0.03	0.07
Income Before Tax	0.62	0.4	0.84	0.3		0.97	0.81	0.6	0.17	0.86	0.37	0.96	0.85	0.81	0.18	0.44	-0.41	-0.03	0.88	-0.73
Net Income	0.49	0.29	0.75	0.2	0.97		0.92	0.51	0.03	0.8	0.48	0.95	0.78	0.78	0.22	0.48	-0.52	-0.18	0.92	-0.83
Income Tax Expense	0.32	0.12	0.59	0.06	0.81	0.92		0.31	-0.18	0.66	0.64	0.83	0.67	0.67	0.29	0.44	-0.71	-0.39	0.88	-0.83
Minority Interest	0.48	0.71	0.86	0.67	0.6	0.51	0.31		0.61	0.53	-0.26	0.49	0.52	0.53	0.16	-0.09	0.2	0.21	0.41	-0.1
Research Development	0.56	0.87	0.53	0.87	0.17	0.03	-0.18	0.61		0.15	-0.65	-0.01	0.11	0.3	-0.13	-0.34	0.57	0.13	-0.14	0.18
Gross Profit	0.61	0.25	0.79	0.13	0.86	0.8	0.66	0.53	0.15		0.47	0.91	0.97	0.85	0.05	0.24	-0.53	0.07	0.89	-0.53
Other Operating Expenses	0.06	-0.53	0.02	-0.6	0.37	0.48	0.64	-0.26	-0.65	0.47		0.52	0.47	0.23	0.0	0.45	-0.95	-0.08	0.66	-0.53
Net Income From Continuing Ops	0.49	0.17	0.74	0.07	0.96	0.95	0.83	0.49	-0.01	0.91	0.52		0.89	0.81	0.19	0.4	-0.55	-0.08	0.97	-0.76
Ebit	0.58	0.26	0.8	0.15	0.85	0.78	0.67	0.52	0.11	0.97	0.47	0.89		0.88	0.01	0.2	-0.57	0.1	0.89	-0.46
Total Operating Expenses	0.52	0.47	0.81	0.4	0.81	0.78	0.67	0.53	0.3	0.85	0.23	0.81	0.88		-0.12	0.09	-0.43	-0.12	0.79	-0.56
Total Other Income Expense Net	-0.08	-0.07	0.13	-0.08	0.18	0.22	0.29	0.16	-0.13	0.05	0.0	0.19	0.01	-0.12		0.14	0.1	-0.49	0.18	-0.21
Tax Provision	-0.02	-0.2	0.03	-0.24	0.44	0.48	0.44	-0.09	-0.34	0.24	0.45	0.4	0.2	0.09	0.14		-0.39	0.1	0.31	-0.54
Net Interest Income	-0.08	0.38	-0.14	0.44	-0.41	-0.52	-0.71	0.2	0.57	-0.53	-0.95	-0.55	-0.57	-0.43	0.1	-0.39		0.15	-0.71	0.53
Interest Income	0.19	0.05	0.04	0.02	-0.03	-0.18	-0.39	0.21	0.13	0.07	-0.08	-0.08	0.1	-0.12	-0.49	0.1	0.15		-0.16	0.5
Ebitda	0.43	0.06	0.68	-0.03	0.88	0.92	0.88	0.41	-0.14	0.89	0.66	0.97	0.89	0.79	0.18	0.31	-0.71	-0.16		-0.74
Reconciled Depreciation	-0.18	0.02	-0.35	0.07	-0.73	-0.83	-0.83	-0.1	0.18	-0.53	-0.53	-0.76	-0.46	-0.56	-0.21	-0.54	0.53	0.5	-0.74

Click cells to compare fundamentals

Shenzhen Glory Account Relationship Matchups

Shenzhen Glory income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	12.1M	17.0M	7.2M	4.4M	2.0M	3.5M
Selling General Administrative	96.4M	246.3M	115.0M	64.9M	54.1M	103.2M
Total Revenue	1.5B	2.3B	1.8B	1.3B	1.2B	1.2B
Operating Income	126.6M	383.2M	95.0M	(6.5M)	(19.9M)	(18.9M)
Cost Of Revenue	1.2B	1.6B	1.4B	1.1B	995.3M	901.2M
Income Before Tax	70.8M	368.5M	89.1M	(384.4M)	(127.6M)	(121.3M)
Net Income Applicable To Common Shares	59.8M	162.1M	59.3M	(308.1M)	(277.3M)	(263.4M)
Net Income	59.8M	162.1M	59.3M	(308.1M)	(148.9M)	(141.4M)
Income Tax Expense	(5.6M)	(1.5M)	1.0M	(56.5M)	(50.8M)	(48.3M)
Minority Interest	479.5M	664.1M	(28.7M)	19.8M	11.9M	11.3M
Research Development	47.9M	61.2M	52.4M	48.2M	40.1M	52.2M
Gross Profit	329.8M	694.7M	362.9M	221.9M	197.6M	319.4M
Other Operating Expenses	15.5M	18.6M	12.1M	10.6M	9.5M	15.0M
Net Income From Continuing Ops	76.4M	369.9M	88.0M	(327.9M)	(160.8M)	(152.8M)
Ebit	49.6M	400.6M	95.0M	(6.5M)	(5.9M)	(5.6M)
Total Operating Expenses	1.4B	1.9B	1.7B	1.3B	1.2B	1.2B
Tax Provision	(5.6M)	(1.5M)	1.0M	(56.5M)	33.2M	34.8M
Net Interest Income	3.9M	(2.9M)	(40.5K)	2.3M	5.1M	5.4M
Interest Income	7.7M	8.7M	5.2M	6.9M	8.7M	7.8M
Ebitda	122.5M	440.6M	111.0M	(254.9M)	(229.4M)	(218.0M)
Reconciled Depreciation	39.6M	55.1M	6.0M	125.0M	95.9M	60.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Shenzhen Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shenzhen Historical Income Statement

About Shenzhen Income Statement Analysis

Shenzhen Glory Income Statement Chart

Total Revenue

Cost Of Revenue

Shenzhen Glory income statement Correlations

Shenzhen Glory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shenzhen Glory income statement Accounts

Also Currently Popular

Other Information on Investing in Shenzhen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 0.99	Total Revenue
Net Income	+ 0.97	Income Before Tax
Ebit	+ 0.97	Gross Profit
Ebitda	+ 0.97	Net Income From Continuing Ops
Net Income From Continuing Ops	+ 0.96	Income Before Tax
Net Income From Continuing Ops	+ 0.95	Net Income

Net Interest Income	- 0.95	Other Operating Expenses
Reconciled Depreciation	- 0.83	Income Tax Expense
Reconciled Depreciation	- 0.83	Net Income
Reconciled Depreciation	- 0.76	Net Income From Continuing Ops
Reconciled Depreciation	- 0.74	Ebitda
Reconciled Depreciation	- 0.73	Income Before Tax